TACOTINIB ER 11: Tofacitinib Extended Release 11 mg for Autoimmune Relief

TACOTINIB ER 11 

 Tofacitinib Extended Release 11 mg

Introduction

TACOTINIB ER 11, featuring Tofacitinib Extended Release 11 mg, is a potent medication used to manage and treat various autoimmune conditions. This article provides an in-depth look at the benefits, indications, and proper administration of TACOTINIB ER 11, emphasizing its effectiveness in controlling symptoms and improving the quality of life for patients.

Key Benefits of Tofacitinib Extended Release 11 mg

Effective Symptom Control

Reduces Inflammation:

• Targeted Action:
  • TACOTINIB ER 11 works by inhibiting specific enzymes involved in the inflammatory process, reducing swelling and pain.
• Consistent Relief:
  • The extended-release formulation ensures consistent symptom control throughout the day.

Improved Mobility

Relieves Joint Pain:

• Enhanced Function:
  • By reducing inflammation, TACOTINIB ER 11 helps improve joint function and mobility.
• Daily Comfort:
  • Patients experience significant relief from daily discomfort and stiffness.

Autoimmune Disease Management

Controls Immune Response:

• Modulates Overactive Immune System:
  • Tofacitinib helps regulate the immune system, preventing it from attacking healthy tissues.
• Prevents Disease Progression:
  • Regular use can slow the progression of autoimmune diseases.

Indications for TACOTINIB ER 11

Rheumatoid Arthritis

Chronic Joint Inflammation:

• Reduces Pain and Swelling:
  • TACOTINIB ER 11 is highly effective in managing chronic joint pain and inflammation associated with rheumatoid arthritis.
• Prevents Joint Damage:
  • By controlling inflammation, it helps prevent long-term joint damage and deformities.

Psoriatic Arthritis

Skin and Joint Symptoms:

• Dual Action:
  • Effective in reducing both skin and joint symptoms in patients with psoriatic arthritis.
• Improves Quality of Life:
  • Helps patients manage the discomfort and visible symptoms associated with the condition.

Ulcerative Colitis

Inflammatory Bowel Disease:

• Symptom Relief:
  • TACOTINIB ER 11 helps manage symptoms such as abdominal pain, diarrhea, and rectal bleeding in patients with ulcerative colitis.
• Induces Remission:
  • Can induce and maintain remission, reducing the frequency of flare-ups.

Dosage and Administration of TACOTINIB ER 11

Recommended Dosage

Adults:

• Standard Dose:
  • The recommended dose is one 11 mg tablet taken once daily, preferably at the same time each day to maintain consistent blood levels.

Administration Instructions

With or Without Food:

• Flexible Intake:
  • TACOTINIB ER 11 can be taken with or without food, offering flexibility in daily routines.

Missed Dose

Take as Soon as Possible:

• Avoid Doubling Up:
  • If a dose is missed, take it as soon as you remember. If it’s almost time for the next dose, skip the missed dose and resume the regular schedule.

Safety Considerations

Common Side Effects

Mild and Manageable:

• Gastrointestinal Issues:
  • Some patients may experience mild gastrointestinal discomfort, such as nausea or diarrhea.
• Headache:
  • Headache is a common side effect but is generally mild and transient.

Serious Side Effects

Rare but Serious:

• Infections:
  • Increased risk of infections due to immune system modulation. Patients should monitor for signs of infection and seek medical attention if needed.
• Liver and Kidney Effects:
  • Regular monitoring of liver and kidney function is recommended during prolonged use.

Precautions

Medical Consultation:

• Before Use:
  • Consult a healthcare provider before starting TACOTINIB ER 11, especially if you have any underlying medical conditions or are taking other medications.
• Regular Monitoring:
  • Regular blood tests are recommended to monitor liver and kidney function during prolonged use.

Conclusion

TACOTINIB ER 11, containing Tofacitinib Extended Release 11 mg, offers effective management of various autoimmune conditions, including rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. By following the recommended dosage and administration guidelines, patients can achieve optimal results and improve their quality of life. Steris Healthcare Pvt Ltd, operating as Sterispharma since its founding by expert professionals in the pharmaceutical industry in February 2018, is based in Navi Mumbai. The company is certified by WHO, GMP, and ISO, emphasizing its commitment to quality and safety. Sterispharma focuses on providing high-quality drugs at affordable prices throughout India, adhering strictly to WHO guidelines. Offering the convenience of an online pharmacy, customers can easily purchase medicines with home delivery options available. Sterispharma's mission is to supply a broad range of healthcare products to meet the diverse needs of the medical community. From advanced treatments and medications for rare conditions to essential health necessities, Sterispharma aims to serve the extensive demands of the healthcare industry. You can order medicines from Sterispharma through their websites, Sterisonline and Sterispharma. Their extensive product lineup includes treatments for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology. 

 For further information 

  Email: info@sterispharma.com / contact@sterispharma.com

  Call/WhatsApp: 7877551268, 7849827488

   BUY NOW